Advertisement
UK markets close in 4 hours 1 minute

  • FTSE 100

    8,091.36
    +50.98 (+0.63%)
     

  • FTSE 250

    19,707.10
    -12.27 (-0.06%)
     

  • AIM

    754.89
    +0.20 (+0.03%)
     

  • GBP/EUR

    1.1663
    +0.0018 (+0.16%)
     

  • GBP/USD

    1.2513
    +0.0051 (+0.41%)
     

  • Bitcoin GBP

    51,008.18
    -2,172.88 (-4.09%)
     

  • CMC Crypto 200

    1,353.85
    -28.73 (-2.08%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.98
    +0.17 (+0.21%)
     

  • GOLD FUTURES

    2,342.10
    +3.70 (+0.16%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,950.27
    -138.43 (-0.77%)
     

  • CAC 40

    8,017.60
    -74.26 (-0.92%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Can the Rally in HUTCHMED (HCM) Shares Continue?

Zacks Equity Research
·1-min read

As of late, it has definitely been a great time to be an investor of HUTCHMED (China) Limited HCM. The stock has moved higher by 28.1% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider HCM’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as HCM has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hutchison China MediTech Limited (HCM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research